NCT00414882
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
- Locations
-
- Municipal Health Department Rio de Janeiro, Brazil
Clinical trial condition
Bacterial Infections
Explore clinical trials studying Bacterial Infections. Study availability and eligibility vary by location and protocol.
4,522 public trials
496 recruiting studies
Bacterial Infections trial results
Completed
Safety of Sublingual dmLT for ETEC
NCT02052934
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Enterobacteriaceae Infections, +4 more
- Locations
-
- Cincinnati Children's Hospital Medical Center - Gastroenterology, Hepatology and Nutrition Cincinnati, Ohio, United States
Completed
Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3
NCT01336699
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +9 more
- Locations
-
- Cincinnati Children's Hospital Medical Center - Infectious Diseases Cincinnati, Ohio, United States
NCT02348424
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +9 more
- Locations
-
- Johns Hopkins Bayview Medical Center - Infectious Diseases Baltimore, Maryland, United States
NCT02073669
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
- Locations
-
- Sheba Medical Center Ramat Gan, Israel
- Israeli Defense Forces Ramat Gan, Israel
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Garran, Australian Capital Territory, Australia
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Westmead, New South Wales, Australia
- GSK Investigational Site Herston, Queensland, Australia
NCT00508261
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Eferding, Austria
- GSK Investigational Site Neufeld/Leitha, Austria
- GSK Investigational Site Salzburg, Austria
- GSK Investigational Site Villach, Austria
NCT03048643
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Buprenorphine, +13 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
NCT03528915
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
- Locations
-
- CHU Amiens-Picardie Amiens, France
Completed
A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.
NCT02017899
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Digestive System Diseases, +9 more
- Locations
-
- Centre d'Investigation Clinique en Vaccinologie Cochin-Pasteur (CIC1417) Paris, Paris Cedex 14, France